Dae Gon Ha
Stock Analyst at Stifel
(1.37)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ABEO Abeona Therapeutics | Maintains: Buy | 21 20 | 5.75 | 247.83% | 2 | May 16, 2025 | |
EDIT Editas Medicine | Downgrades: Hold | 11 3 | 2.27 | 32.16% | 4 | Dec 13, 2024 | |
SLNO Soleno Therapeutics | Maintains: Strong Buy | 59 74 | 83.24 | -11.1% | 2 | Oct 1, 2024 | |
FULC Fulcrum Therapeutics | Downgrades: Hold | 22 3 | 7.08 | -57.63% | 4 | Sep 12, 2024 | |
INZY Inozyme Pharma | Initiates Coverage On: Buy | 16 | 4 | 300% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 64 | 9.56 | 569.46% | 2 | Sep 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 204 220 | 138.96 | 58.32% | 4 | Sep 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 66 | 51.02 | 29.36% | 3 | Jun 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 124 127 | 36.51 | 247.85% | 2 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 56 40 | 11.3 | 253.98% | 3 | Apr 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 16 | n/a | n/a | 1 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 48 | 2.52 | 1804.76% | 4 | Sep 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 4 | n/a | n/a | 4 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 2.42 | 643.8% | 1 | Apr 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 7 | n/a | n/a | 1 | Mar 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 1 | n/a | n/a | 4 | Oct 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 86 52 | n/a | n/a | 5 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 23 25 | 62.59 | -60.06% | 4 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 12 16 | 5.94 | 169.36% | 3 | Nov 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 285 | 9.01 | 3063.15% | 1 | Sep 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 2.04 | 880.39% | 1 | May 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 252 | n/a | n/a | 1 | Mar 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 168 | n/a | n/a | 1 | Mar 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Sep 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Jun 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Jun 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 0.83 | 1345.78% | 1 | Jun 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 237 | n/a | n/a | 1 | Jun 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Jun 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 600 490 | 9.21 | 5220.3% | 2 | Oct 23, 2017 |